RMED stock forecast
Our latest prediction for Ra Medical Systems, Inc.'s stock price was made on the Dec. 17, 2019 when the stock price was at 0.77$.
In the short term (2weeks), RMED's stock price should underperform the market by -7.14%. During that period the price should oscillate between -18.95% and +24.59%.
In the medium term (3months), RMED's stock price should underperform the market by -20.88%. During that period the price should oscillate between -44.29% and +54.64%.Get email alerts
About Ra Medical Systems, Inc.
Ra Medical Systems, Inc. engages in the design, development, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its product, Pharos, is used for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. It operates through the Dermatology and Vascular business segments. The company was founded by Dean Irwin and Melissa Burstein in 2002 and is headquartered in Carlsbad, CA.
At the moment the company generates 8M USD in revenues.
On its last earning announcement, the company reported a loss of -5.03$ per share.
The book value per share is 5.26$
Three months stock forecastDec. 17, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|